2025年的暂定议程

CHI第三届年度会议

Clinical Trial Venture, Innovation & Partnering
临床试验风险投资、创新和合作伙伴关系

Accelerating Innovation, Accessibility and Scale
加速创新可及性规模

2025年2月4日～5日（所有时间均为美国东部标准时间）

SCOPE Summit 的“临床试验风险投资、创新和合作”会议将于 2025 年 2 月 4~5 日在佛罗里达州奥兰多举行。 该顶级会议将与第 16 届 SCOPE 峰会（临床运营高管峰会）一起举行。 第三届年度临床试验风险投资、创新和合作伙伴关系会议将汇集临床试验领域的高级投资者、高管、企业家和初创公司领导者。这项高级别活动内容包括发人深省的行业主导小组讨论、炉边谈话以及为首席执行官、投资者和潜在收购者提供的众多交流机会，以助您建立有意义的人脉。诚挚邀请您参加本次以风险和创新为焦点的会议，以获得宝贵的策略见解、坦诚的观点以及合作和投资的实用商业建议。此外，您还将有机会探索展厅，与该领域的新兴企业和老牌企业建立联系，使您能够掌握行业的发展方向。
Preliminary Agenda

Co-Chair Welcome Remarks

Jessica J. Federer, Board Member, Angelini Ventures

NAVIGATING THE CLINICAL TRIAL INVESTMENT LANDSCAPE: INNOVATION, OPPORTUNITIES, AND MARKET INSIGHTS

KEYNOTE:

Unlocking Opportunities: Market Overview and Investment Landscape in Clinical Trial Venture and Innovation

Shane C. Senior, Managing Director & Owner, Crosstree Capital Partners, Inc.

PANEL DISCUSSION:

Where Are Investors Placing Their Bets? An Oxford Style Debate

PANEL MODERATOR:

Jessica J. Federer, Board Member, Angelini Ventures

PANELISTS:

Dana Callow, Founder & Managing Partner, Boston Millennia Partners

Sunny Kumar, Partner, GSR Ventures

Carrie Williams, Vice President & Partner, McKesson Ventures

PANEL DISCUSSION:

Identifying and Addressing Pharma's Unmet Needs: Strategic Insights for Investment

PANEL MODERATOR:

Jodi Akin, Founding CEO, Hawthorne Effect, Inc.

PANELISTS:

Brian Matesic, Principal, Norwest Venture Partners

PANEL DISCUSSION:

How Is Pharma Rethinking Clinical Trials and Investments?

PANEL MODERATOR:

Jeremy P. Goldberg, Operating Partner, Healthcare, Arsenal Capital Partners

PANELISTS:

John R. Pavletic, Executive Director, Lilly Ventures

Dave Stevenson, Managing Director, Merck Global Health Innovation Fund

INVESTING IN THE FUTURE OF CLINICAL TRIALS: TRENDS, RISKS, AND POTENTIAL

Co-Chair Remarks

Rana Lonnen, Managing Director, Novartis

PANEL DISCUSSION:

Leading the Future of Clinical Trials: CEO and Founders Perspectives on Innovation and Transformation

PANEL MODERATOR:

Rana Lonnen, Managing Director, Novartis

PANELISTS:

Scott Chetham, PhD, CEO & Co-Founder, Faro Health

Emmanual Walckenaer, CEO, Yseop

Chairperson's Remarks

Zach Taft, CEO, IgniteData

PANEL DISCUSSION:

Investing in AI for Clinical Trials: Navigating Risk and Maximizing ROI

PANEL MODERATOR:

Mitesh Rao, MD, Founder & CEO, OMNY

PANELISTS:

Sameer Badlani, MD, FACP, Chief Strategy Officer & Chief Digital Officer, Fairview Health Services

Jill Johnston, Chief Innovation Officer, WCG Clinical

Interviewed By:

Brigham Hyde, CEO, Atropos Health & Venture Partner, Audere Capital LLC, Atropos Health

PANEL DISCUSSION:

Unlocking the Patient Recruitment Puzzle: A Smart Investment in Enhancing the Patient Experience and the Future of Trials

PANEL MODERATOR:

Laura Y. Hilty, Principal, Investments & Growth, HealthX Ventures

PANELISTS:

Denise Bronner, PhD, Founder & CEO, Empactful Ventures

Eirini Scholosser, Founder & CEO, Dyania Health

Delmonize Smith, PhD, Co-Founder & CEO, Acclinate

Co-Chair Closing Remarks

Sunny Kumar, Partner, GSR Ventures


* 活动内容有可能不事先告知作更动及调整。